Study Of Diabetic Nephropathy With Atrasentan
Clinical trial NCT01858532 · TERMINATED
Trial details
- NCT number
- NCT01858532
- Sponsor
- AbbVie
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-17
- Primary completion
- 2018-03-29
- Enrollment
- 5107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.